TNF and neoplasm: The combination of decreased TNFα, IL-1β, and COX-2 found in the PDTC treated epidermis provides compelling evidence that Hr is capable of modulating epithelial inflammation via regulation of the NFκB pathway and thereby further contributes to tumor promotion.